Barclays lowered the firm’s price target on C4 Therapeutics (CCCC) to $5 from $10 and keeps an Overweight rating on the shares. The firm adjusted price targets in the biotechnology space as part of ...

Add articles to your saved list and come back to them any time. Bulls N’ Bears Dollar Bill has enjoyed (but often ignored) the advice of the same broker for nearly thirty years. George was an old ...

The world's biggest film industry has a new breakout star – artificial intelligence. While Indian cinema is embracing AI far more readily than Hollywood, the use of the technology isn't pleasing ...